Tag: Acalabrutinib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Acalabrutinib

CALQUENCE Plus Obinutuzumab Demonstrated Sustained Survival Benefit in 1st-line ... - Benzinga

Added to Collection on: 2022-06-04 20:21:25

Tags for this article:

Clinical medicine
Drugs
Cancer
Antineoplastic drugs
Breakthrough therapy
Orphan drugs
Non-Hodgkin lymphoma
Lymphoma
Obinutuzumab
Chronic lymphocytic leukemia
Acalabrutinib
Rituximab
chlorambucil
Idelalisib
AstraZeneca
Bendamustine

Click the tags to see associated articles and topics

View Article Details
Long-Term Follow-Up Supports Acalabrutinib-Based Regimens in Treatment-Naïve CLL

Added to Collection on: 2022-06-04 19:55:38

Tags for this article:

Antineoplastic drugs
Cancer treatments
Drugs
Medicine
Orphan drugs
Breakthrough therapy
Acalabrutinib
Chronic lymphocytic leukemia
Obinutuzumab
Nitrogen mustards
Progression-free survival
Chemoimmunotherapy

Click the tags to see associated articles and topics

View Article Details
Long-Term Follow-Up Continues to Show Acalabrutinib-Based Regimens Superior to ...

Added to Collection on: 2022-06-04 17:18:04

Tags for this article:

Antineoplastic drugs
Health sciences
Health
Medicine
Orphan drugs
Breakthrough therapy
Acalabrutinib
Obinutuzumab
Chronic lymphocytic leukemia
Progression-free survival
Chemoimmunotherapy
Clinical endpoint

Click the tags to see associated articles and topics

View Article Details
Calquence Demonstrates Sustained Survival Benefit for CLL - Pharmacy Times

Added to Collection on: 2022-06-05 13:41:28

Tags for this article:

Drugs
Health sciences
Health
Breakthrough therapy
Orphan drugs
Antineoplastic drugs
Nitrogen mustards
Organochlorides
Obinutuzumab
Chronic lymphocytic leukemia
Acalabrutinib
Leukemia
chlorambucil
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
Global Bruton Tyrosine Kinase (BTK) Inhibitors Market | Key players are Pfizer Inc Acerta ...

Added to Collection on: 2022-06-06 19:19:20

Tags for this article:

Enzymes
Orphan drugs
Branches of biology
Drugs
Tyrosine kinase inhibitors
Breakthrough therapy
Bruton's tyrosine kinase
Zanubrutinib
Acalabrutinib
Tyrosine kinase
Chronic lymphocytic leukemia
Protein kinase inhibitor

Click the tags to see associated articles and topics

View Article Details
AstraZeneca demonstrates pipeline and portfolio strength across malignant and ... - Mirage News

Added to Collection on: 2022-06-09 08:09:00

Tags for this article:

Health sciences
Drugs
Health
Orphan drugs
Breakthrough therapy
Antineoplastic drugs
Tyrosine kinase inhibitors
Drug discovery
Chronic lymphocytic leukemia
Acalabrutinib
Obinutuzumab
Rituximab
Alexion
AstraZeneca
Calquence

Click the tags to see associated articles and topics

View Article Details
Japan approves AstraZeneca's Calquence for adult patients with treatment-naïve CLL

Added to Collection on: 2022-12-29 08:37:03

Tags for this article:

RTT
Medicine
Clinical medicine
Cancer
Tyrosine kinase inhibitors
Breakthrough therapy
Chronic lymphocytic leukemia
Acalabrutinib
SLL
Leukemia
Lymphoma
CLL
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
Ascentage Pharma and AstraZeneca Investment Co., Ltd. Enter into Clinical Collaboration ...

Added to Collection on: 2023-10-16 16:02:14

Tags for this article:

Antineoplastic drugs
Orphan drugs
Peripheral membrane proteins
Tyrosine kinase inhibitors
Acalabrutinib
Chronic lymphocytic leukemia
Bruton's tyrosine kinase
Bcl-2
AstraZeneca
Targeted therapy
Ibrutinib
P110α
AstraZeneca Group

Click the tags to see associated articles and topics

View Article Details
Lilly cancer drug cleared by FDA for expanded leukemia, lymphoma use - BioPharma Dive

Added to Collection on: 2023-12-04 17:24:48

Tags for this article:

Orphan drugs
Breakthrough therapy
Antineoplastic drugs
Tyrosine kinase inhibitors
Piperidines
Bruton's tyrosine kinase
Ibrutinib
AbbVie
Obinutuzumab
Chemotherapy
Acalabrutinib
Chronic lymphocytic leukemia
Eli Lilly

Click the tags to see associated articles and topics

View Article Details
Evolving Front-line Treatment Options for CLL - Cancer Network

Added to Collection on: 2023-12-18 22:08:57

Tags for this article:

Orphan drugs
Breakthrough therapy
Tyrosine kinase inhibitors
Tyrosine kinases
Piperidines
Bruton's tyrosine kinase
Acalabrutinib
Zanubrutinib
Obinutuzumab
Chronic lymphocytic leukemia
Lymphoid leukemia
Leukemia
Mayo Clinic

Click the tags to see associated articles and topics

View Article Details